Diabetes is a growing crisis in Nigeria, affecting over 11 million people. With treatment costs soaring—like insulin prices jumping from N3,500 in 2022 to N26,000 in 2024—managing diabetes is a financial burden. Mega Lifesciences has responded by launching the WeCare Diabetes App, a groundbreaking tool to enhance diabetes management. Debuting at the EMSON conference, the app empowers patients with real-time support, logging tools, and expert advice. It also bridges gaps between patients and doctors by fostering seamless communication, especially in remote regions. This aligns with Mega Lifesciences’ mission of educating and empowering individuals for better health. Can digital tools like this really transform healthcare accessibility in rural areas?
For more details, visit the original source.
